Use-dependent regulation of GABAA receptors - PubMed (original) (raw)
Review
Use-dependent regulation of GABAA receptors
E M Barnes Jr. Int Rev Neurobiol. 1996.
Abstract
Prolonged occupancy of GABAA receptors by ligands, including GABA and benzodiazepine agonists, sets in motion a series of mechanisms that can be termed use-dependent regulation. These mechanisms can be subdivided into two distinct pathways, one for GABAA receptor downregulation and another for upregulation. Treatment of cortical neurons with GABA or benzodiazepines in cultures opens the pathway for GABAA receptor downregulation, which includes (in putative temporal order): (1) desensitization (tachyphylaxis), (2) sequestration (endocytosis) of subunit polypeptides and uncoupling of allosteric interactions between GABA and benzodiazepine binding sites, (3) subunit polypeptide degradation, and (4) repression of subunit gene expression. The end-point of GABAA receptor downregulation, a reduction in receptor number, is postulated to be established initially by degradation of the receptor protein and then maintained by a diminished level of de novo synthesis. Benzodiazepine treatment of many preparations, including cells expressing recombinant GABAA receptors, may elicit only desensitization, sequestration, or uncoupling, without a decline in receptor number. Components of the GABAA receptor downregulation pathway are also evoked by chronic administration of GABAmimetics, benzodiazepines, barbiturates, and neurosteroids in animals. This downregulation correlates with the establishment of tolerance to and physical dependence on the pharmacological effects of these drugs, suggesting a cellular model for this behavior. The upregulation of GABAA receptors is observed as one of the neurotrophic actions of GABA, primarily in cultured cerebellar granule cells. Upregulation in culture is caused by enhanced expression of genes for GABAA receptor subunits and correlates with the establishment of GABAergic circuitry in the developing cerebellum. Thus, both the upregulation and downregulation of GABAA receptors appear to represent use-dependent pathways for guiding synaptic plasticity in the vertebrate central nervous system.
Similar articles
- GABA-induced uncoupling of GABA/benzodiazepine site interactions is mediated by increased GABAA receptor internalization and associated with a change in subunit composition.
Gutiérrez ML, Ferreri MC, Gravielle MC. Gutiérrez ML, et al. Neuroscience. 2014 Jan 17;257:119-29. doi: 10.1016/j.neuroscience.2013.10.077. Epub 2013 Nov 9. Neuroscience. 2014. PMID: 24215979 - Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha 1 subunit protein in rat cerebellar granule cells.
Brown MJ, Bristow DR. Brown MJ, et al. Br J Pharmacol. 1996 Jul;118(5):1103-10. doi: 10.1111/j.1476-5381.1996.tb15512.x. Br J Pharmacol. 1996. PMID: 8818332 Free PMC article. - GABA-induced uncoupling of GABA/benzodiazepine site interactions is associated with increased phosphorylation of the GABAA receptor.
Gutiérrez ML, Ferreri MC, Farb DH, Gravielle MC. Gutiérrez ML, et al. J Neurosci Res. 2014 Aug;92(8):1054-61. doi: 10.1002/jnr.23387. Epub 2014 Apr 10. J Neurosci Res. 2014. PMID: 24723313 - Regulation of GABAA receptor structure and function by chronic drug treatments in vivo and with stably transfected cells.
Klein RL, Harris RA. Klein RL, et al. Jpn J Pharmacol. 1996 Jan;70(1):1-15. doi: 10.1254/jjp.70.1. Jpn J Pharmacol. 1996. PMID: 8822084 Review. - From ion currents to genomic analysis: recent advances in GABAA receptor research.
Rabow LE, Russek SJ, Farb DH. Rabow LE, et al. Synapse. 1995 Nov;21(3):189-274. doi: 10.1002/syn.890210302. Synapse. 1995. PMID: 8578436 Review.
Cited by
- Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA.
Wang P, Eshaq RS, Meshul CK, Moore C, Hood RL, Leidenheimer NJ. Wang P, et al. Front Cell Neurosci. 2015 May 18;9:188. doi: 10.3389/fncel.2015.00188. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26041994 Free PMC article. - Neurosteroids and GABA-A Receptor Function.
Wang M. Wang M. Front Endocrinol (Lausanne). 2011 Oct 4;2:44. doi: 10.3389/fendo.2011.00044. eCollection 2011. Front Endocrinol (Lausanne). 2011. PMID: 22654809 Free PMC article. - Modulation of ligand-gated ion channels by antidepressants and antipsychotics.
Rammes G, Rupprecht R. Rammes G, et al. Mol Neurobiol. 2007 Apr;35(2):160-74. doi: 10.1007/s12035-007-0006-1. Mol Neurobiol. 2007. PMID: 17917105 Review. - GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia?
Bengtsson SKS, Bäckström T, Brinton R, Irwin RW, Johansson M, Sjöstedt J, Wang MD. Bengtsson SKS, et al. Neurobiol Stress. 2019 Dec 20;12:100206. doi: 10.1016/j.ynstr.2019.100206. eCollection 2020 May. Neurobiol Stress. 2019. PMID: 31921942 Free PMC article. - The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome.
Bird LM, Ochoa-Lubinoff C, Tan WH, Heimer G, Melmed RD, Rakhit A, Visootsak J, During MJ, Holcroft C, Burdine RD, Kolevzon A, Thibert RL. Bird LM, et al. Neurology. 2021 Feb 16;96(7):e1024-e1035. doi: 10.1212/WNL.0000000000011409. Epub 2020 Dec 21. Neurology. 2021. PMID: 33443117 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources